Herald of Medicine mainly publishes medical academic papers related to drugs, with the exception of herbal medicine cultivation, traditional Chinese medicine identification, chemical drug structural identification and drug synthesis, pharmacy education, etc. The contents include frontiers, hot spots and focuses of pharmacy, basic research on drugs, pharmaceutical preparation process, drug quality control, drug clinical efficacy observation, drug safety evaluation, drug system evaluation and Meta-analysis, pharmacy management, etc.

It has columns such as "Special Contribution" "Standards, Guidelines and Consensus" "Drug Research" "Drug and Clinical" "Advances in Pharmacy" "Drug Formulation and Drug Quality Control" "Introduction of New Drugs" " Rational Drug Use " "Clinical Pharmacist Communication Corner" "Adverse Drug Reactions and Adverse Events"” Digital & Intelligent Pharmacy ” "Pharmacy Management", etc. Each issue has a column on drug treatment of a certain type of drug or disease.
1 Special Contribution
Generally, the editorial board invites experts to analyze, discuss or comment on the current hot topics, focal points and difficult issues in the field of medicine.
2 Standards, Guidelines and Consensus
It publishes the latest standards, guidelines and expert consensus on the use of drugs in various clinical specialties and interprets the changes in drug use in the latest clinical diagnosis and treatment guidelines. Generally, the editorial staff will organize and invite manuscripts to relevant experts or academic associations.
3 Drug Research
It reports original research of Chinese and Western medicines, covering pharmaceutical studies, pharmacological and toxicological studies, blood concentration monitoring, pharmacokinetic studies, drug bioequivalence studies, etc.
4 Drug and Clinical
It publishes papers aiming for investigating the clinical effectiveness and safety of drugs, including all phases of clinical trials of new drugs and clinical studies of marketed drugs. The multicenter and large sample clinical trials of new drugs are warmly welcomed.
5 Featured Column
The column follows the major special projects and organizes a series of articles with multi-perspective and multi-directional coverage based on the hot spots, focal points and difficult issues of the pharmaceutical industry. The types of paper include review, comment, thesis, case study, etc. Each column contains about six papers.
6 Advances in Pharmacy
This column calls for the papers that summarize, analyze and refine the original research data, information and main ideas of a drug (or a class of drugs) or a treatment method over a period of time. Such articles required strong professionalism, concentrated issues and the content should have a certain depth and timeliness, which can reflect the historical background, research status and development trend of the topic. These reviews will help readers to quickly understand the latest research trends of the topic and the main original research papers in the field.
7 Drug Formulation and Quality Control
This column mainly reports on prescription screening, process optimization, production technology improvement in the process of new drug development and improvement of hospital formulation preparation methods. It also includes research papers on the exploration of quality control methods for drugs that have not yet established quality standards, the improvement of existing drug quality control methods, and innovative quality control methods for hospital preparations.
8 Rational Drug Use
This column mainly reports on the rationality of drug clinical application, analysis of drug compatibility, stability of drugs, drug effectiveness and safety re-evaluation, system evaluation and Mata analysis, etc.
9 Clinical Pharmacist Communication Corner
This part includes articles that systematically introduce the participation of clinical pharmacists in the pharmacy service process of typical cases, analyze of medication cases, make medication regimens based on patients' conditions (symptoms, signs, laboratory test results, etc.) and blood concentration monitoring results, analyze adverse drug reaction cases, etc.
10 Adverse Drug Reactions and Adverse Events
It mainly reports new or unintended adverse reactions (including side effects, toxic reactions, allergic reactions, residual effect, secondary effects, idiosyncratic reactions and carcinogenic, teratogenic and mutagenic effects, etc.) and important medical events related to drugs after the use of marketed drugs. It also includes systematic analyses and reviews of adverse reactions occurring with a drug or a class of drugs by literature review.
11 Digital & Intelligent Pharmacy
The column focuses on reporting advancements in pharmacy informatization construction, pharmacy automation, smart pharmacy, pharmacy-algorithm integration, real-world data research, and the development of pharmacists' digital competencies. It also covers cutting-edge technologies and their applications, such as pharmacy information intelligence, knowledge graphs, machine learning, artificial intelligence (AI) in pharmacy, and network pharmacology.
12 Pharmacy Management
The content covers the interpretation of the latest domestic and international pharmacy regulations, scientific management in the field of pharmacy and other experience summaries.
13 Introduction of New Drugs
This column mainly introduces new drugs with indications for major diseases that have recently been approved for the first time by the drug administration departments of the United States and the European Union. Their indications, dosage forms, usage and dosage, medication precautions, adverse reactions, non-clinical pharmacology and toxicology, clinical pharmacology and toxicology, clinical research and intellectual property status, and domestic and international research progress are briefly introduced.